Morepen Laboratories announced that the Hon'ble Securities Appellate Tribunal (SAT) by an order pronounced on 15 April 2021 (hosted on website of the SAT on 24 April 2021), quashed and set aside the Order dated 24 September 2019 passed by the Securities and Exchange
Board of India (SEBI) whereby SEBI had restrained the company from buying, selling or otherwise dealing in securities and accessing the securities markets for one year from the date of the SEBI Order.
It may be mentioned that the SEBI order relates to a GDR issued made by the company way back in 2003.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
